Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.55 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.54 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL584565 | 1.00 | CYP1A1 (0.55) | CYP1A1CYP1B1SMN1; SMN2LMNAMAPT | |
| SCHEMBL30278658 | 1.00 | CYP1A1 (0.55) | CYP1A1CYP1B1SMN1; SMN2LMNAMAPT | |
| SCHEMBL7134078 | 0.93 | CYP1A1 (0.50) | CYP1A1CYP1B1SMN1; SMN2LMNAMAPT | |
| SCHEMBL1124353 | 0.85 | SMN1; SMN2 (0.54) | SMN1; SMN2LMNAMAPTHTTKDM4E | |
| SCHEMBL14303656 | 0.85 | CYP1A1 (0.55) | CYP1A1CYP1B1SMN1; SMN2LMNAMAPT | |
| SCHEMBL1124351 | 0.85 | SMN1; SMN2 (0.54) | SMN1; SMN2LMNAMAPTHTTKDM4E | |
| SCHEMBL31501091 | 0.85 | SMN1; SMN2 (0.54) | SMN1; SMN2LMNAMAPTHTTKDM4E | |
| SCHEMBL2865211 | 0.85 | CYP1A1 (0.55) | CYP1A1CYP1B1SMN1; SMN2LMNAMAPT | |
| SCHEMBL31356822 | 0.85 | CYP1A1 (0.55) | CYP1A1CYP1B1SMN1; SMN2LMNAMAPT | |
| SCHEMBL2865213 | 0.85 | CYP1A1 (0.55) | CYP1A1CYP1B1SMN1; SMN2LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025081932-A1 | RETINOL DERIVATIVE OR SALT THEREOF, AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳市护家科技有限公司 | 2025-04-24 | — | — | WO | claimed |
| EP-2268614-B1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO KK (JP) | 2013-05-15 | — | — | EP | claimed |
| US-8258340-B2 | Method for producing β-mercapto carboxylic acids | SHOWA DENKO K.K. (JP) | 2012-09-04 | — | — | US | claimed |
| EP-2205557-B1 | METHOD FOR PRODUCING BETA-MERCAPTOCARBOXYLIC ACIDS | SHOWA DENKO KK (JP) | 2012-02-29 | — | — | EP | claimed |
| US-20110015436-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2011-01-20 | — | — | US | claimed |
| US-20110004017-A1 | METHOD FOR PRODUCING B-MERCAPTOCARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2011-01-06 | — | — | US | claimed |
| EP-2268614-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | Showa Denko K.K. (JP) | 2011-01-05 | — | — | EP | claimed |
| WO-2009113711-A1 | METHOD FOR PRODUCING -MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2009-09-17 | — | — | WO | claimed |
| WO-2025081932-A1 | RETINOL DERIVATIVE OR SALT THEREOF, AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳市护家科技有限公司 | 2025-04-24 | — | — | WO | disclosed |
| EP-3802122-B1 | METHOD OF MAKING AN ANTIMICROBIAL MULTILAYER FILM | CRYOVAC LLC (US) | 2023-08-16 | — | — | EP | disclosed |
| US-11325357-B2 | Method of making an antimicrobial multilayer film | CRYOVAC, LLC (US) | 2022-05-10 | — | — | US | disclosed |
| CN-108840871-B | 13-hydroxy cytisine cinnamate compound with anti-tumor activity and preparation method thereof | 西安泰科迈医药科技股份有限公司 | 2021-12-17 | — | — | CN | disclosed |
| US-20210213713-A1 | METHOD OF MAKING AN ANTIMICROBIAL MULTILAYER FILM | CRYOVAC, LLC | 2021-07-15 | — | — | US | disclosed |
| EP-3802122-A1 | METHOD OF MAKING AN ANTIMICROBIAL MULTILAYER FILM | Cryovac, LLC (US) | 2021-04-14 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| US-5708018-A | 2-aminoindans as selective dopamine D3 ligands | PHARMACIA & UPJOHN COMPANY (US) | 1998-01-13 | — | — | US | disclosed |
| US-5539074-A | LIQUID CRYSTAL POLYMERS ON SILICA FOR LIGHT SENSITIVE ELEMENTS | HOFFMANN-LA ROCHE INC. (US) | 1996-07-23 | — | — | US | disclosed |
| EP-0712387-A1 | 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS | PHARMACIA & UPJOHN COMPANY (US) | 1996-05-22 | — | — | EP | disclosed |
| WO-1995004713-A1 | 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS | THE UPJOHN COMPANY (US) | 1995-02-16 | — | — | WO | disclosed |
| US-4059618-A | CROSSLINKING | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015436-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | CBS, ALDH7A1, CBR1 | CYP1A1 122/4885CYP1B1 93/4885SMN1; SMN2 2240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.